BIONEXUS GENE LAB CORP Stock Prediction
AI-powered sentiment analysis and prediction trends for BGLC, updated each market day.
BGLC AI Sentiment
AI sees no strong directional signal for BIONEXUS GENE LAB CORP stock over the next 10 market days.
Prediction date: May 20, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About BIONEXUS GENE LAB CORP
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
Sector
Exchange
Market Cap
$4,786,281
Cap Tier
Employees
1
Headquarters
KUALA LUMPUR, N8
Listed Since
March 11, 2020
Website
BGLC Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BGLC Volatility
BIONEXUS GENE LAB CORP has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
